Portage Biotech (Portage Biotech) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Portage Biotech FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Portage Biotech's Free Cash Flow for the three months ended in Dec. 2023 was $-3.43 Mil. Portage Biotech's Revenue for the three months ended in Dec. 2023 was $0.00 Mil. Therefore, Portage Biotech's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Portage Biotech's current FCF Yield % is -243.37%.

The historical rank and industry rank for Portage Biotech's FCF Margin % or its related term are showing as below:

PRTG's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -148.24
* Ranked among companies with meaningful FCF Margin % only.

Portage Biotech FCF Margin % Historical Data

The historical data trend for Portage Biotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Portage Biotech FCF Margin % Chart

Portage Biotech Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Margin %

Get a 7-Day Free Trial

Portage Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Portage Biotech's FCF Margin %

For the Biotechnology subindustry, Portage Biotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Portage Biotech's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Portage Biotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Portage Biotech's FCF Margin % falls into.

Portage Biotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Portage Biotech's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	-12.076	/	0
	=	%

Portage Biotech's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-3.431	/	0
	=	%

Portage Biotech FCF Margin % Related Terms

Thank you for viewing the detailed overview of Portage Biotech's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Portage Biotech (Portage Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Portage Biotech Inc (NAS:PRTG) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Clarence Thomas Building, P.O. Box 4649, Tortola, Road Town, VGB, VG1110

Website

https://www.portagebiotech.com

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.